Kopsavilkums
The authors would like to make the following corrections to this published paper [1]. In the original manuscript, Figure 10A contained an error in the labeling of the X-axis (Log Dilution). The correct dilutions used for the serum were from 1/20 to 1/160, which correspond to log dilutions approximately from log 1.3 to log 2.2. Therefore, the X-axis should have been labeled as 1.2 to 2.4, rather than 2.2 to 3.4. We apologize for this oversight and have corrected the figure accordingly to reflect the accurate dilution range. The corrected Figure 10 is listed below: The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
| Oriģinālvaloda | Angļu |
|---|---|
| Raksta numurs | 1189 |
| Žurnāls | Vaccines |
| Sējums | 12 |
| Izdevuma numurs | 10 |
| DOIs |
|
| Publikācijas statuss | Publicēts - okt. 2024 |
| Ārēji publicēts | Jā |
ANO IAM
Šis izpildes rezultāts palīdz sasniegt šādus ANO ilgtspējīgas attīstības mērķus (IAM)
-
3. IAM — Laba Veselība un Labbūtība
Nospiedums
Uzziniet vairāk par pētniecības tēmām “Correction to: Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes (Vaccines, (2024), 12, 8, (874), 10.3390/vaccines12080874)”. Kopā tie veido unikālu nospiedumu.Citēt šo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver